Mingfa Group (International) Company Limited – Progress Update on PRC Subsidiaries’ Board Restructuring (May 2026)
Key Highlights
- Mingfa Group (International) Company Limited has released its latest monthly update regarding the restructuring of the boards of directors for its PRC (People’s Republic of China) subsidiaries.
- As of the announcement date (29 May 2026), only two PRC subsidiaries are still pending regulatory approval for their proposed director changes.
- The restructuring process is nearly complete, pending final approvals from the relevant PRC local regulatory bureaus.
- The company will continue to provide monthly updates regarding the progress of these restructuring efforts.
- The Board’s current composition, including executive, non-executive, and independent non-executive directors, is also disclosed.
Details of the Announcement
Mingfa Group (International) Company Limited (“the Company”), listed on the Hong Kong Stock Exchange (Stock Code: 00846), has issued an important update for investors and shareholders on the ongoing restructuring of the boards of directors of its PRC subsidiaries.
This restructuring process has been communicated to the market through a long series of monthly updates since February 2021. The company has provided consistent disclosure on the progress, underlining its commitment to transparency and regulatory compliance.
As of 29 May 2026, the Company reports that only two subsidiaries in the PRC have yet to complete the regulatory procedure for the change of directors. These subsidiaries have already submitted their applications for the change to the competent local regulatory bureaus, and approvals are currently pending.
Once these final approvals are received and the changes are officially registered, the restructuring of the boards of directors at the subsidiary level will be complete.
The Company’s continued monthly updates signal that the process is being closely monitored and is in its final stages. This transparency is crucial for investors concerned about the governance and management structure of the group’s PRC operations.
Potential Price Sensitive Information
- The near completion of the restructuring process could have a positive impact on the Company’s corporate governance profile, potentially enhancing investor confidence.
- Delays or issues with the remaining regulatory approvals could impact the Company’s operations and reputation in the PRC.
- Investors should monitor forthcoming monthly updates for any material developments that could affect the share price, especially if the final two approvals are delayed or denied.
Board Composition
- Executive Directors: Mr. Ng Man Fung Walter, Ms. Shang Xuan, Mr. Huang Zhibin
- Non-executive Directors: Dr. Lam, Lee G. (Chairman), Ms. Chen Bihua
- Independent Non-executive Directors: Mr. Lau Kin Hon, Mr. Chu Kin Wang Peleus, Mr. Chan Sing Lai
Outlook for Investors
Investors are advised to closely track further announcements from Mingfa Group, as the completion of this restructuring process could mark a significant change in the company’s governance and risk profile in the PRC. Any unexpected delays or challenges in obtaining the final regulatory approvals could also have an adverse impact.
The Company has reiterated its commitment to making further announcements on any material progress, ensuring that shareholders remain updated on this potentially price-sensitive matter.
Disclaimer
This article is prepared for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with professional advisors before making investment decisions. The information above is based on the Company’s official disclosures as of 29 May 2026.
明發集團（國際）有限公司 – 關於中國附屬公司董事會重組最新進展（2026年5月）
重點摘要
- 明發集團（國際）有限公司發佈了中國附屬公司董事會重組的最新月度進展報告。
- 截至公告日（2026年5月29日），僅剩兩家附屬公司待有關部門批準董事變更申請。
- 重組程序已接近完成，只待相關地方監管局最終批准。
- 公司將繼續就重組進展每月公告，保持資訊透明。
- 董事會現有組成，包括執行董事、非執行董事及獨立非執行董事等，亦已披露。
公告詳情
明發集團（國際）有限公司（「本公司」，香港聯交所上市，股份代號：00846）發佈了有關中國附屬公司董事會重組進展的重要信息，供投資者及股東參考。
此項重組自2021年2月起已連續多月向市場作出更新，展現公司對資訊披露及監管合規的重視。
截至2026年5月29日，僅餘兩家中國附屬公司尚待地方監管局批準其董事變更申請，相關申請已經提交，目前正等待審批。
一旦取得最終批文並完成變更登記，集團附屬層面的董事會重組將全部完成。
公司持續每月公告此事項，顯示對流程的高度關注及臨近完成階段。此舉對於關心中國業務管理架構的投資者而言尤為重要。
潛在對股價敏感訊息
- 重組接近完成，有助於提升公司企業管治形象，或可增強投資者信心。
- 如最終監管批文延遲或出現問題，可能影響公司在中國的經營及聲譽。
- 投資者宜密切留意後續公告，尤其是最終兩間附屬公司的審批進展，因其有可能影響股價。
董事會組成
- 執行董事： 吳文豐先生、尚璇女士、黃志斌先生
- 非執行董事： 林家禮博士（董事會主席）、陳碧華女士
- 獨立非執行董事： 劉建漢先生、朱健宏先生、陳勝禮先生
投資者展望
投資者應密切關注明發集團的後續公告，因重組完成或標誌著公司在中國的管治及風險狀況將有重大變化。若最終審批出現延誤或障礙，亦可能對公司帶來負面影響。
公司重申將就任何重大進展及時公告，確保股東掌握這一或具價格敏感性的事項。
免責聲明
本文僅供參考，並不構成任何投資建議。投資者應自行進行盡職調查，並諮詢專業顧問後作出投資決策。以上資訊以公司2026年5月29日公告為依據。
